
51 - 200 employees
Founded 2007
🏥 Healthcare
🔧 Hardware
💰 $42M Series D - Phagenesis on 2024-03
Healthcare • Hardware
Phagenesis is a medical technology company that developed the Phagenyx System, a bedside neurostimulation device delivering pharyngeal electrical stimulation (PES) to restore swallowing function and accelerate recovery from post-stroke dysphagia. Supported by more than 30 publications and recent inclusion of PES in the American Heart Association/American Stroke Association guideline, Phagenyx is CE marked and has received FDA de novo classification for sale in the United States; it is intended for use in adult patients with neurogenic dysphagia and is used in hospitals and critical care settings to enable earlier oral nutrition and reduce aspiration risk, ICU time, and overall length of stay.
🔥 1 hour ago
Director of Marketing leading Phagenesis's US commercial marketing initiatives. Overseeing brand strategy, lead generation, and sales enablement for Phagenyx.
🇺🇸 United States – Remote
💰 $42M Series D - Phagenesis on 2024-03
⏰ Full Time
🔴 Lead
🎯 Chief Marketing Officer (CMO)